Special Issue "Pulmonary Hypertension: Symptoms, Diagnosis and Management"

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pulmonary".

Deadline for manuscript submissions: 10 February 2024 | Viewed by 1090

Special Issue Editors

Prof. Dr. Skaidrius Miliauskas
E-Mail Website
Guest Editor
Department of Pulmonology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania
Interests: pulmonary vascular diseases; lung cancer
Prof. Dr. Eglė Ereminienė
E-Mail Website
Guest Editor
Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania
Interests: heart left ventricle; pulmonary hypertension; echocardiography

Special Issue Information

Dear Colleagues,

This Special Issue is focused on the most recent data covering the various aspects of pulmonary hypertension, including clinical presentation, diagnosis confirmation, and management. Multiple etiologies cause elevated blood pressure in pulmonary arteries. Although several approved and recently introduced treatment possibilities exist, including the medications mostly for Group I (pulmonary arterial hypertension) and Group IV (pulmonary hypertension associated with pulmonary artery obstructions), the prognosis is poor. After the closure of small pulmonary arteries, the patients die due to the progressing failure of the right ventricle. There is an unmet need for a better understanding of this pathology for better management and patient care.

The aim and scope of this Special Issue are to help and encourage scientists working in this area to publish their data.

Prof. Dr. Skaidrius Miliauskas
Prof. Dr. Eglė Ereminienė
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pulmonary hypertension
  • cardiopulmonary exercise testing
  • lung function tests
  • echocardiography
  • cardiopulmonary exercise testing
  • lung function tests
  • cardiac magnetic resonance imaging

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

9 pages, 295 KiB  
Brief Report
Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019–2020
Medicina 2023, 59(8), 1426; https://doi.org/10.3390/medicina59081426 - 06 Aug 2023
Viewed by 828
Abstract
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and progressive condition; however, the true characteristics of CTEPH are still unknown, as notable regional variations exist in terms of patients’ age, baseline hemodynamic data, and management choices. This report aims to investigate [...] Read more.
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and progressive condition; however, the true characteristics of CTEPH are still unknown, as notable regional variations exist in terms of patients’ age, baseline hemodynamic data, and management choices. This report aims to investigate the baseline clinical characteristics, incidence, and risk factors associated with CTEPH patients in Latvia from 2019 to 2020. Methods: The data were analyzed from a prospective, nationwide, Latvian pulmonary hypertension registry for incident CTEPH cases. The patients’ clinical characteristics were assessed at the time of diagnosis. Results: During the course of this study, a cohort of 13 patients with CTEPH were included for analysis. Among the enrolled CTEPH patients, most exhibited low exercise and functional capacity, with a median (±IQR) 6 min walk distance of 300.0 (±150.0) m. The median values (±IQR) for mean pulmonary artery pressure and pulmonary vascular resistance were 40.0 ± 13.0 mmHg and 7.35 ± 2.82 Wood units, respectively. The most common risk factors for CTEPH were a history of acute pulmonary embolism and a blood group other than O. Conclusions: The findings of this report revealed the characteristics of the Latvian CTEPH population, indicating that a significant proportion of patients are elderly individuals with multiple comorbidities. Full article
(This article belongs to the Special Issue Pulmonary Hypertension: Symptoms, Diagnosis and Management)
Back to TopTop